SHRC
DEAD

Serial Number

97821718

Owner

Dimension Genomics Inc

Attorney

Dana Dickson

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SHRC Trademark

Serial Number: 97821718

SHRC is a trademark filed by Dimension Genomics Inc on March 3, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Dimension Genomics Inc (4 trademarks)

4326 Falcon St
San Diego, CA 92103

Entity Type: 03

Trademark Details

Filing Date

March 3, 2023

Registration Date

Not Registered

Goods & Services

Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use

Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use

Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use

Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Medical diagnostic services, medical diagnostic testing and reporting services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical use

Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use

Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 14, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 14, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 26, 2024 CNRT
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 2, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 5, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 5, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 5, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023 NWOS
NEW APPLICATION ENTERED
Mar 7, 2023 NWAP